Volker Rethwisch

4.1k total citations · 1 hit paper
9 papers, 1.0k citations indexed

About

Volker Rethwisch is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Volker Rethwisch has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Volker Rethwisch's work include Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Acute Myeloid Leukemia Research (3 papers). Volker Rethwisch is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Acute Myeloid Leukemia Research (3 papers). Volker Rethwisch collaborates with scholars based in Germany, Netherlands and United States. Volker Rethwisch's co-authors include Stephan Probst, Nils Homann, Claudia Pauligk, Ralf‐Dieter Hofheinz, Elke Jäger, Jan Stoehlmacher, J. T. Hartmann, G. Seipelt, Akin Atmaca and Salah‐Eddin Al‐Batran and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Volker Rethwisch

9 papers receiving 1.0k citations

Hit Papers

Phase III Trial in Metastatic Gastroesophageal Adenocarci... 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
    2008 568 citations Salah‐Eddin Al‐Batran, J. T. Hartmann et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Volker Rethwisch Germany 6 753 456 421 284 162 9 1.0k
Y-K. Kang South Korea 15 476 0.6× 454 1.0× 229 0.5× 177 0.6× 131 0.8× 39 749
Paul Nyandoto Finland 8 759 1.0× 582 1.3× 294 0.7× 180 0.6× 85 0.5× 13 1000
M. Planker Germany 11 432 0.6× 475 1.0× 183 0.4× 143 0.5× 55 0.3× 16 714
MC Nicolson United Kingdom 11 980 1.3× 750 1.6× 454 1.1× 217 0.8× 119 0.7× 20 1.2k
Aurore Blesius France 12 352 0.5× 336 0.7× 171 0.4× 163 0.6× 215 1.3× 26 677
Pier Paolo Fattori Italy 10 253 0.3× 275 0.6× 74 0.2× 94 0.3× 97 0.6× 24 642
Shigeki Seki Japan 5 512 0.7× 186 0.4× 446 1.1× 56 0.2× 83 0.5× 10 690
I. L. Ray-Coquard France 13 231 0.3× 262 0.6× 186 0.4× 114 0.4× 74 0.5× 47 655
Nadine Röthling Germany 8 495 0.7× 311 0.7× 406 1.0× 81 0.3× 45 0.3× 11 658
Motonori Sairenji Japan 16 812 1.1× 314 0.7× 457 1.1× 329 1.2× 123 0.8× 68 1.1k

Countries citing papers authored by Volker Rethwisch

Since Specialization
Citations

This map shows the geographic impact of Volker Rethwisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Rethwisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Rethwisch more than expected).

Fields of papers citing papers by Volker Rethwisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Rethwisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Rethwisch. The network helps show where Volker Rethwisch may publish in the future.

Co-authorship network of co-authors of Volker Rethwisch

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Rethwisch. A scholar is included among the top collaborators of Volker Rethwisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Rethwisch. Volker Rethwisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Al‐Batran, Salah‐Eddin, Claudia Pauligk, Nils Homann, et al.. (2012). The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+). European Journal of Cancer. 49(4). 835–842. 102 indexed citations
3.
Lübbert, Michael, Björn Rüter, Rainer Claus, et al.. (2011). A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy. Haematologica. 97(3). 393–401. 172 indexed citations
4.
Al-Batran, S-E., Nils Homann, J. T. Hartmann, et al.. (2010). 5-fluorouracil, leucovorin, and oxaliplatin with or without docetaxel in elderly (65 years or older) patients with esophagogastric cancer: FLOT65+ trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).. Journal of Clinical Oncology. 28(15_suppl). 4013–4013. 10 indexed citations
5.
6.
7.
Al‐Batran, Salah‐Eddin, J. T. Hartmann, Stephan Probst, et al.. (2008). Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology. 26(9). 1435–1442. 568 indexed citations breakdown →
8.
9.
Al-Batran, S-E., J. T. Hartmann, Ralf‐Dieter Hofheinz, et al.. (2007). Modified FOLFOX in combination with docetaxel for patients with metastatic adenocarcinoma of the stomach or gastroesophageal junction: A multicenter phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Journal of Clinical Oncology. 25(18_suppl). 4545–4545. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y-K. Kang Breakdown of academic impact, for papers by Paul Nyandoto Breakdown of academic impact, for papers by M. Planker Breakdown of academic impact, for papers by MC Nicolson Breakdown of academic impact, for papers by Aurore Blesius Breakdown of academic impact, for papers by Pier Paolo Fattori Breakdown of academic impact, for papers by Shigeki Seki Breakdown of academic impact, for papers by I. L. Ray-Coquard Breakdown of academic impact, for papers by Nadine Röthling Breakdown of academic impact, for papers by Motonori Sairenji
Rankless by CCL
2026